About this approach
Cancer treatment vaccines aim to train an immune response against features of an existing cancer. They differ from preventive vaccines, such as HPV vaccination, which reduce the risk of certain cancers before they develop. An established treatment example is sipuleucel-T for a specific advanced prostate-cancer setting. Many personalized or neoantigen vaccines are still being studied.
Where it fits: Limited established applications; many personalized vaccines remain investigational
Where this treatment is used
Sipuleucel-T is approved in the United States for selected people with metastatic castration-resistant prostate cancer who have no symptoms or only minimal symptoms. Its evidence cannot be transferred to an unrelated dendritic-cell product or a vaccine marketed for many different tumors. Other treatment vaccines may use tumor antigens, a patient’s immune cells or personalized molecular information and are often evaluated with other therapies in clinical trials. A promising immune response or laboratory result does not by itself demonstrate longer survival or better quality of life.
Procedure and practical considerations
Possible adverse effects include fever, chills, fatigue, nausea and reactions during administration. Product-specific risks may be more serious, and research vaccines can have additional uncertainties. Collecting a patient’s cells may involve its own procedure and scheduling demands. A treatment described as personalized or natural is not automatically harmless.
Clinics reporting this approach
These clinic profiles connect to this approach through clinic-confirmed selections or Cancer Clinic Finder’s source review. Open a profile to compare locations, services, practical details, and ways to get started.
1 connected profile
Browse all 1 connected profileSources
Source information checked: 2026-09-29. The links below identify the public and clinic-provided materials used for this page.
- NCI: Cancer Treatment Vaccines ↗Checked 2026-09-29
- NCI: Sipuleucel-T ↗Checked 2026-09-29
- FDA: Provenge product information ↗Checked 2026-09-29
How Cancer Clinic Finder compiles information · Suggest a factual correction